Pharmaceuticals

Inhalation technology that helps put you in front, faster

Biocare Manufacturing is a State-of-Art Manufacturing facility dedicated for the manufacturing of Metered Dose Inhalers. Our pharmaceuticals manufacturing unit have Malaysian GMP with PIC/S accreditation.

WHY TO CHOOSE
METER DOSE INHALERS

MDI has been the most widely used platform in the treatments for Asthma and COPD. It is estimated that there are 300 million asthma and 230 million COPD sufferers worldwide. MDIs are well suited to meet the needs of the price sensitive and largely generic developing world markets. Both MDIs and dry-powder inhalers (DPIs) combine to form a market valued at US$37 billion. Of the 920 million devices sold each year, MDIs represent about 60% of the volume and 40% of the sales value

WHY TO CHOOSE
BIOCARE’s MDI

  • Expertise in Technologies
  • Componentry – Advanced valve technology ensure dosing uniformity
    Hardware Design – patient-friendly devices
  • Canister Design – Reduce drug degradation and deposition
  • All components and hardware are sourced from UK to ensure 100% quality at
  • par with any world class manufacturers
  • State-of-Art fully dedicated for MDI plant with WHO-GMP, PIC/S Malaysia
  • Approved plant

QUALITY CONTROL

We exercise a sound Quality Management System and adopting current Good Manufacturing Practices complying with all regulatory requirements. Our products are ready for registration with International standard ACTD / CTD Dossiers

OUR PRODUCTS

Single Drug Products

Brand Name  Generic Name  Action Strength Metered Doses
Biomol Salbutamol Bronchodilators
(Anti-cholinergic)
100 mcg 200 MD
Biozone Beclomethasone Anti inflammatory
Agents Cortiscosteroids
100 mcg 200 MD

Combination Products

Brand Name  Generic Name  Action Strength Metered Doses
Salmetrol
Fluticazone
Salmetrol
Fluticazone
Anti-cholinergic +
Bronchodilators
25mg + 125 mcg 120 MD
Salmetrol 25mg+
Fluticazone 250mcg
Salmetrol 25mg+
Fluticazone 250mcg
Bronchodilators +
Corticosteroids
25mg + 125 mcg 121 MD

Phase II Manufacturing

Biocare’s second phase manufacturing which is under construction now is expected to be commercialized by the end of 2022. The BCM-2 will manufacture Dry Powder Inhalers (DPIs), Nasal Sprays etc., to offer a complete range of Respiratory Medicines.

BCM-2 will be a fully integrated manufacturing facility with Malaysian GMP with PIC/S accreditation. The facility

Brand Name  Generic Name 
Dry Powder Inhaler Budesonide
Fluticasone propionate
Budesonide/formoterol
Formeterol Fumarate
Salmeterol + Fluticasone
Brand Name  Generic Name 
Nasal Spray Fluticasone
Oxymetazoline
Saline Nasal Spray